{"name":"Navigen, Inc.","slug":"navigen-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxNOXlSc3JjVFBNSDlOMkJ6S2Y4a2k5LVlHUTUxLWZMd19uYkhsQzlvNVRmNi1NcmFVWjJ6NTNJaElPT0NQTjFVbDlzdmlxLTNSaWZkM3dlbzBidnpYbGtxZWs5ZDF1S0o5ekxGM1ZvTm1LOHZOa3Q0QkEweEdoeVVJdmlFSWh4SXFrM0VFSGlCZlNfMXNraXpYYlVhbkVUUXlEaUJmdy1VOWFSMXd4OGNYLTExeHpYd0tDN1ZlbjR2WkpoVk5BVV9ENDFfdzNrUkN2RUpkdUU4cUZKSjA1WUlSRlFNalZGbngwaWFJNVRoUGpCeGdmTDdjZVVES1drSGNyblZBSng5ZzdySC1heF9GcWxabVFCY0JLbzk3OXAwX0Z5cFJYb20zUTdrckRZMU5YVkxR?oc=5","date":"2019-12-10","type":"regulatory","source":"GlobeNewswire","summary":"Navigen Announces FDA Clearance of its IND Application to - GlobeNewswire","headline":"Navigen Announces FDA Clearance of its IND Application to","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2018-10-03","type":"pipeline","source":"Newswise","summary":"University Venture Fund Ii Is First Money in Navigen Pharmaceuticals Seed Round | Newswise - Newswise","headline":"University Venture Fund Ii Is First Money in Navigen Pharmaceuticals Seed Round | Newswise","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}